NCT07360886Recruiting
Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
This study aims to develop accessible methods for the early detection of selected neuropathologies in drivers, focusing on multiple sclerosis and Parkinson's disease. The primary objective is to identify clinical tests that correlate with outcomes from the Vienna Test System (VTS), thereby enabling early diagnosis without the need for complex neurological or neuropsychological assessments. Findings could improve the effectiveness of routine driver medical check-ups and inform future modifications to Czech traffic law to enhance road safety.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 13 Jan 2026
- Start date
- 1 May 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University Hospital Olomouc
- Diseases
- Parkinson disease, Multiple sclerosis
- NCT number
- NCT07360886
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 May 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- In the second cohort (patients with Multiple Sclerosis), proven and treated relapse in the last 6 weeks before inclusion in the study.
Other illness
- Proven diagnosis of dementia based on a current psychological examination (MMSE 24 points or less).
- Diagnosis of a disease or condition that, according to Czech Law. No. 277/2004 Coll., on medical fitness to drive motor vehicles, as amended (especially Law No. 204/2025 Coll.), prevents or significantly limits the ability to drive a motor vehicle safely (e.g. dementia, epilepsy, severe disorders of consciousness).
Lab values
- For both cohorts, evidence of parainfectious deterioration as demonstrated by laboratory testing.
Age
- Age less than 18 years.
- Age more than 85 years.
Other
- In the MS cohort, current EDSS \> 6.5 points.
- For the PD cohort, the current Hoehn and Yahr scale score is greater than or equal to 4.
Who the study is looking for
- Person after signing informed consent.
- After meeting the valid diagnostic criteria for the given neurological diagnosis.
- Possession of a valid driver's license and proof of active driving.
- Age limit 18 - 85 years.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Olomouc Coordinator of this site? Confirm its status | Olomouc | Czechia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.